Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $2.31 in the prior trading day, Nuvation Bio Inc (NYSE: NUVB) closed at $2.27, down -1.73%. In other words, the price has decreased by -$1.73 from its previous closing price. On the day, 3.07 million shares were traded. NUVB stock price reached its highest trading level at $2.3575 during the session, while it also had its lowest trading level at $2.225.
Ratios:
Our goal is to gain a better understanding of NUVB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.57 and its Current Ratio is at 9.57. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Wang Junyuan Jerry sold 56,361 shares for $2.89 per share. The transaction valued at 162,883 led to the insider holds 3,866,228 shares of the business.
Mashal Robert bought 100,000 shares of NUVB for $220,000 on Oct 08 ’24. The Director now owns 100,000 shares after completing the transaction at $2.20 per share. On Jun 25 ’24, another insider, Cui Xiangmin, who serves as the Director of the company, bought 277,895 shares for $2.97 each. As a result, the insider paid 825,348 and bolstered with 2,453,131 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 764007104 and an Enterprise Value of 226063008. For the stock, the TTM Price-to-Sale (P/S) ratio is 354.76 while its Price-to-Book (P/B) ratio in mrq is 1.52. Its current Enterprise Value per Revenue stands at 104.562 whereas that against EBITDA is -1.688.
Stock Price History:
The Beta on a monthly basis for NUVB is 1.45, which has changed by 0.42592597 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is -15.85%, while the 200-Day Moving Average is calculated to be -20.14%.
Shares Statistics:
The stock has traded on average 2.61M shares per day over the past 3-months and 2488490 shares per day over the last 10 days, according to various share statistics. A total of 335.25M shares are outstanding, with a floating share count of 228.71M. Insiders hold about 32.25% of the company’s shares, while institutions hold 43.25% stake in the company. Shares short for NUVB as of 1736899200 were 22053600 with a Short Ratio of 8.45, compared to 1734048000 on 15405571. Therefore, it implies a Short% of Shares Outstanding of 22053600 and a Short% of Float of 9.2.